Brent crude was up 36 cents, or 0.5%, at $65.60 a barrel by 1212
GMT, and U.S. crude rose 39 cents, or 0.6%, to $62.09 a barrel.
Both contracts rose more than $1 earlier in the session.
"Vaccine news is helping oil, as the likely removal of mobility
restrictions over the coming months on the back of vaccine
rollouts should further boost the oil demand and price
recovery," said UBS oil analyst Giovanni Staunovo.
Commerzbank analyst Eugen Weinberg said optimistic oil price
forecasts issued by leading U.S. brokers had also contributed to
the latest upswing in prices.
Goldman Sachs expects Brent prices to reach $70 per barrel in
the second quarter from the $60 it predicted previously, and $75
in the third quarter from $65 forecast earlier.
Morgan Stanley expects Brent crude to climb to $70 in the third
quarter.
"New COVID-19 cases are falling fast globally, mobility
statistics are bottoming out and are starting to improve, and in
non-OECD countries, refineries are already running as hard as
before COVID-19," Morgan Stanley said in a note.
Bank of America said Brent prices could temporarily spike to $70
per barrel in the second quarter.
Disruptions in Texas caused by last week's winter storm also
supported oil prices. Some U.S. shale producers forecast lower
oil output in the first quarter.
Stockpiles of U.S. crude oil and refined products likely
declined last week, a preliminary Reuters poll showed on Monday.
A weaker dollar also provided some support to oil as crude
prices tend to move inversely to the U.S. currency.
(Reporting by Bozorgmehr Sharafedin in London, additional
reporting by Jessica Jaganathan in Singapore; editing by David
Evans and John Stonestreet)
[© 2021 Thomson Reuters. All rights
reserved.] Copyright 2021 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|